Life Science Company News

Reset
Results 461 - 480 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23 24  25 »

Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidance

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Ipsen SA

Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Pharming Group N.V.

RELIFE BY A. MENARINI CHAMPIONS PERSONAL CHOICE IN AESTHETIC TREATMENTS, ENCOURAGING SELF-CARE AND SELF-LOVE

Read more ››
By: PR Newswire Association LLC. - 24 Apr 2024

GenScript Singapore's Open Day Reveals Pioneering AI Capabilities in Recombinant Protein Production and Drug Discovery

Read more ››
By: PR Newswire Association LLC. - 24 Apr 2024

Hanmi Enters into Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate BH3120 in Combination with KEYTRUDA® (pembrolizumab)

Read more ››
By: PR Newswire Association LLC. - 24 Apr 2024

Glycated Albumin Assay Market Projected to Reach $360.92 million by 2030 - Exclusive Report by 360iResearch

Read more ››
By: PR Newswire Association LLC. - 24 Apr 2024

Green Water Labs to Host Community Clean-Up Event in Celebration of Earth Day 2024

Read more ››
By: GlobeNewswire - 24 Apr 2024

Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting

Read more ››
By: PR Newswire Association LLC. - 24 Apr 2024
Related companies:  Astellas Pharma Inc.

Day One’s OJEMDA™ (tovorafenib) Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Common Form of Childhood Brain Tumor

Read more ››
By: GlobeNewswire - 23 Apr 2024
Related companies:  Day One Biopharmaceuticals, Inc.

Pennant Announces First Quarter 2024 Earnings Release and Call

Read more ››
By: GlobeNewswire - 23 Apr 2024

Seer to Report First Quarter 2024 Financial Results on May 8, 2024

Read more ››
By: GlobeNewswire - 23 Apr 2024
Related companies:  Seer, Inc.

ClearPoint Neuro to Announce First Quarter 2024 Results May 7, 2024

Read more ››
By: GlobeNewswire - 23 Apr 2024
Related companies:  ClearPoint Neuro, Inc.

TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K

Read more ››
By: GlobeNewswire - 23 Apr 2024

Clover Health to Report First Quarter 2024 Financial Results on May 7, 2024

Read more ››
By: GlobeNewswire - 23 Apr 2024

Shuttle Pharmaceuticals to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024

Read more ››
By: GlobeNewswire - 23 Apr 2024
Related companies:  Shuttle Pharmaceuticals

OpGen Receives Nasdaq Notice Regarding Delayed Form 10-K

Read more ››
By: GlobeNewswire - 23 Apr 2024
Related companies:  OpGen, Inc.

Precision Optics to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024

Read more ››
By: GlobeNewswire - 23 Apr 2024
Related companies:  Precision Optics Corporation, Inc.

Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares

Read more ››
By: GlobeNewswire - 23 Apr 2024
Related companies:  Centessa Pharmaceuticals Limited

Silk Road Medical to Present at the BofA Securities 2024 Healthcare Conference

Read more ››
By: GlobeNewswire - 23 Apr 2024
Related companies:  Silk Road Medical,Inc.

Neuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference Call

Read more ››
By: GlobeNewswire - 23 Apr 2024
Related companies:  Neuronetics, Inc.
Results 461 - 480 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23 24  25 »

Enhance your business development with Biotechgate
Try for free »